AIM: To investigate the etiology and managementof a poorly understood complication of transjugularintrahepatic portosystemic shunt; "endotipsitis".METHODS: A MEDLIN
The mechanism of action of ribavirin (RBV) as an immunomodulatory and antiviral agent and its clinicalsignificance in the future treatment of patients withhepatit
Chronic hepatitis C virus(HCV) is a global concern. With the 2014 Food and Drug Administration approvals of two direct-acting antiviral(DAA) regimens, ledipasvi